Physicians’ Perspective on Diabetes Mellitus Management within the Context of Personalized Medicine Era in Tabuk Governorate, Saudi Arabia
Open accessAbstract
BACKGROUND: Minimizing the number of therapy failures and decreasing the diabetic complications can be achieved by the application of personalising diabetes therapy, based on patient`s genetics, however, currently, personalised Medicine (PM) in diabetes mellitus management is not extensively applied. AIM: To assess the knowledge, attitudes, and willingness of physicians in practising of PM in diabetes management. METHODS: A cross-sectional analytical study was implemented among 126 physicians from six different governmental hospitals and 12 primary care centres selected by the stratified random sampling technique in the Tabuk region of Saudi Arabia. A structured self-administered questionnaire was utilised for data collection. A simple scoring system (scale of 5 points) was utilised to assess knowledge and willingness. Likert scale was applied to evaluate the attitudes towards practising PM in DM management by the fixed choice response formats. RESULTS: The majority of the participants (97.62%) claimed not receiving any PM and/or genomic medicine training. Most of them (82.54%) expressed unsatisfactory knowledge concerning personalised DM, whereas the medium level of attitudes was reported among 57.14% of them and a good level of willingness had been observed among 76.98% of the physicians. CONCLUSION: Emphasizing on essential personalised DM management knowledge aspects should be given a considerable priority. Fortunately, positive attitudes and goodwill of physicians towards PM are encouraging and should be supported by policymakers.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The majority of professionals have a positive attitude towards precision medicine in general or towards interventions labeled as precision medicine.
“Various studies reveal that the majority of professionals have a positive attitude towards PM in general or towards interventions, which are mentioned under the label of PM [27, 34, 43, 45, 47, 50, 79–83].”
From Patients’ and professionals’ views related to ethical issues in precision medicine: a mixed research synthesis (2021) · cites this paper as [82]
Professionals describe a lack in their own knowledge or a limited understanding of precision medicine.
“Professionals also describe a lack in their own knowledge or a limited understanding, as quantitative studies demonstrate [36, 37, 44, 81, 82, 92, 103, 104].”
From Patients’ and professionals’ views related to ethical issues in precision medicine: a mixed research synthesis (2021) · cites this paper as [82]
In Saudi Arabia, 27.8% of physicians surveyed doubted that patients would have easy access to precision medicine.
“For example, in Saudi Arabia, where healthcare is predominantly taxpayer-funded [109], 27.8% of physicians surveyed (n = 126) doubted that patients would have easy access to PM [82].”
From Patients’ and professionals’ views related to ethical issues in precision medicine: a mixed research synthesis (2021) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Measuring the global burden of disease
Murray, C. J. L., & Lopez, A. D. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1201534 · Cited by 1,818 · see citing works
Generalization in quantitative and qualitative research: Myths and strategies
Polit, D. F., & Beck, C. T. (2010) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2010.06.004 · Cited by 1,767 · see citing works
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Shu, Y., Sheardown, S. A., Brown, C., Owen, R., Zhang, S., Castro, R. A., Ianculescu, A. G., Lin, Y., Lo, J. C.-M., Burchard, E. G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30558 · Cited by 971 · see citing works
Genetic Factors in Type 2 Diabetes: The End of the Beginning?
O’Rahilly, S., Barroso, I., & Wareham, N. J. (2005) · Science · doi:10.1126/science.1104346 · Cited by 252 · see citing works
The Prospects for “Personalized Medicine” in Drug Development and Drug Therapy
Woodcock, J. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100063 · Cited by 179 · see citing works
Sesti, G., Laratta, E., Cardellini, M., Andreozzi, F., Guerra, S. D., Irace, C., Gnasso, A., Grupillo, M., Lauro, R., Hribal, M. L., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2323 · Cited by 157 · see citing works
Owusu Obeng, A., Fei, K., Levy, K. D., Elsey, A. R., Pollin, T. I., Ramirez, A. H., Weitzel, K. W., & Horowitz, C. R. (2018) · Journal of Personalized Medicine · doi:10.3390/jpm8030024 · Cited by 131 · see citing works
Yamagishi, S., Ueda, S., & Okuda, S. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207781757051 · Cited by 119 · see citing works
Personalized medicine in diabetes mellitus: current opportunities and future prospects
Kleinberger, J. W., & Pollin, T. I. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12757 · Cited by 104 · see citing works
Chow-White, P. A., Ha, D. T., & Laskin, J. J. (2017) · Human Resources for Health · doi:10.1186/s12960-017-0218-z · Cited by 89 · see citing works
An Evaluation of Pharmacists‘ Expectations Towards Pharmacogenomics
de Denus, S., Letarte, N., Hurlimann, T., Lambert, J.-P., Lavoie, A., Robb, L. J., Sheehan, N. L., Turgeon, J., & Vadnais, B. (2013) · Pharmacogenomics · doi:10.2217/pgs.12.197 · Cited by 82 · see citing works
Riedel, A. A., Heien, H. C., Wogen, J., & Plauschinat, C. A. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.8.1102 · Cited by 76 · see citing works
Personalized Medicine in Diabetes
Malandrino, N., & Smith, R. J. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.156901 · Cited by 72 · see citing works
Collins, C. D., Purohit, S. B., Podolsky, R. H., Zhao, H., Schatz, D., Eckenrode, S., Yang, P., Hopkins, D., Muir, A., Hoffman, M., et al. (2006) · Vascular Pharmacology · doi:10.1016/j.vph.2006.08.003 · Cited by 65 · see citing works
Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients
Ruaño, G., Goethe, J. W., Caley, C. F., Woolley, S. B., Holford, T. R., Kocherla, M., Windemuth, A., & de León, J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001944 · Cited by 63 · see citing works
Skipping toward Personalized Molecular Medicine
Hoffman, E. P. (2007) · New England Journal of Medicine · doi:10.1056/nejme0707795 · Cited by 62 · see citing works
Personalized Medicine for Diabetes
Klonoff, D. C. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200301 · Cited by 60 · see citing works
Ciardiello, F., Adams, R., Tabernero, J., Seufferlein, T., Taieb, J., Moiseyenko, V., Ma, B., Lopez, G., Vansteenkiste, J. F., Esser, R., et al. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0279 · Cited by 53 · see citing works
Pacanowski, M. A., Hopley, C. W., & Aquilante, C. L. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.5.529 · Cited by 35 · see citing works
The History of Personalized Medicine
Abrahams, E., & Silver, M. (2010) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195393804.003.0001 · Cited by 35 · see citing works
McWilliam, A., Lutter, R., & Nardinelli, C. (2008) · Personalized Medicine · doi:10.2217/17410541.5.3.279 · Cited by 34 · see citing works
Precision Medicine, Personalized Medicine, Omics and Big Data: Concepts and Relationships
Zhang, X. D. (2015) · Journal of Pharmacogenomics & Pharmacoproteomics · doi:10.4172/2153-0645.1000e144 · Cited by 32 · see citing works
Chakrabarti, R., Finger, R. P., Lamoureux, E. L., Islam, M. T., Dirani, M., Bhuiyan, A., Islam, S. Z., Wahab, M. A., & Islam, A. F. M. (2015) · Bangladesh Journal of Medical Science · doi:10.3329/bjms.v14i4.25767 · Cited by 18 · see citing works
Importance of Race and Ethnicity in Individuals’ Use of and Responses to Genomic Information
Kaphingst, K. A., & Goodman, M. S. (2015) · Personalized Medicine · doi:10.2217/pme.15.39 · Cited by 17 · see citing works
Personalized medicine and comparative effectiveness research in an era of fixed budgets
Brown, P. (2010) · The EPMA Journal · doi:10.1007/s13167-010-0058-6 · Cited by 13 · see citing works
Using Personalized Medicine in the Management of Diabetes Mellitus
Elk, N., & Iwuchukwu, O. F. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1976 · Cited by 10 · see citing works
Pharmacogenomics in type 2 diabetes management: towards personalized medicine
Hu, C. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-s2-a19 · Cited by 4 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- [1]International Diabetes Federation (IDF), IDF DIABETES ATLAS Seventh edition, 2015 Available from: https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/13-diabetes-atlas-seventh-edition.html
- [18]European Commission, Health Research Directorate Personalised Medicine-Opportunities and Challenges for European HealthCare. Workshop report 2010 Available from: https://ec.europa.eu/research/health/pdf/13th-european-health-forum-workshop-report_en.pdf
Cited by
Sorted by citations
Erdmann, A., Rehmann-Sutter, C., & Bozzaro, C. (2021) · BMC Medical Ethics · doi:10.1186/s12910-021-00682-8 · Cited by 86 · see citing works
Rahma, A. T., Elsheik, M., Ali, B. R., Elbarazi, I., Patrinos, G. P., Ahmed, L. A., & Al‐Maskari, F. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040216 · Cited by 39 · see citing works
From one size fits all to a tailored approach: integrating precision medicine into medical education
Sbitan, L., Alzraikat, N., Tanous, H., Saad, A. M., & Odeh, M. M. (2025) · BMC Medical Education · doi:10.1186/s12909-024-06138-y · Cited by 16 · see citing works
Kamp, M., Pain, O., May, A. K., Lewis, C. M., & Ramsay, M. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091360 · Cited by 9 · see citing works
Khan, M., Jahan, S., Abrar, N., Saleem, L., Mazhar, R., & Hussain, A. (2020) · Journal of Rawalpindi Medical College · doi:10.37939/jrmc.v24isupp-1.1410
- Authors
- Alharbi, A. A., Shaqran, T. M., Eltobgy, A. A. E., Albalawi, A. R., & Alnawmasi, W. S.
- Affiliations
- Al-Azhar University (EG)
- King Fahad Specialist Hospital (SA)
- Corresponding author
- Alharbi, Asma Ali
- Venue
- Open Access Macedonian Journal of Medical Sciences
- Published
- 2019-05-27
- Volume
- 7
- Issue
- 10
- Pages
- 1706-1711
- ISSN
- 1857-9655 (ISSN-L)
- PMC
- PMC6560294
- OpenAlex
- W2947077119
- Cited by
- 5
- References
- 28
- Citations by year
- 2025: 1 · 2022: 1 · 2021: 1 · 2020: 2
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Open Access Macedonian Journal of Medical Sciences (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Nutrition, Genetics, and Disease
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes management, personalized medicine, physician knowledge, physician attitudes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
